IDXX logo

IDEXX Laboratories, Inc. Stock Price

NasdaqGS:IDXX Community·US$55.1b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 48 Fair Values set on narratives written by author

IDXX Share Price Performance

US$669.00
249.17 (59.35%)
US$785.00
Fair Value
US$669.00
249.17 (59.35%)
12.6% undervalued intrinsic discount
US$765.08
Fair Value
Price US$669.00
AnalystHighTarget US$765.08
AnalystConsensusTarget US$702.17
AnalystLowTarget US$417.08

IDXX Community Narratives

AnalystHighTarget·
Fair Value US$785 14.8% undervalued intrinsic discount

Global Pet Ownership And AI Diagnostics Will Expand Market Opportunities

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AnalystConsensusTarget·
Fair Value US$754.83 n/aintrinsic discount

IDXX: Expanding Installed Base Will Drive Accelerating Business Momentum Ahead

0users have liked this narrative
0users have commented on this narrative
19users have followed this narrative
AnalystLowTarget·
Fair Value US$497.21 34.6% overvalued intrinsic discount

Declining Pet Ownership And Rising Compliance Costs Will Erode Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Snowflake Analysis

Outstanding track record with excellent balance sheet.

1 Risk
2 Rewards

IDEXX Laboratories, Inc. Key Details

US$4.2b

Revenue

US$1.6b

Cost of Revenue

US$2.6b

Gross Profit

US$1.5b

Other Expenses

US$1.0b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 02, 2026
12.87
61.72%
24.65%
62.8%
View Full Analysis

About IDXX

Founded
1983
Employees
11000
CEO
Jonathan Mazelsky
WebsiteView website
www.idexx.com

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, it offers diagnostic tests, services, and related instrumentation for manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Recent IDXX News & Updates

Recent updates

No updates